According to Merck's latest financial reports the company's current EPS (TTM) is ยฃ1.40. In 2022 the company made an earnings per share (EPS) of ยฃ4.42 an increase over its 2021 EPS that were of ยฃ3.98.
Year | EPS | Change |
---|---|---|
2023 (TTM) | ยฃ1.55 | -64.89% |
2022 | ยฃ4.42 | 10.92% |
2021 | ยฃ3.98 | 84.68% |
2020 | ยฃ2.16 | -27.2% |
2019 | ยฃ2.96 | 63.44% |
2018 | ยฃ1.81 | 151.11% |
2017 | ยฃ0.72 | -54.58% |
2016 | ยฃ1.59 | 30.21% |
2015 | ยฃ1.22 | -61.99% |
2014 | ยฃ3.21 | 180.51% |
2013 | ยฃ1.14 | -31.82% |
2012 | ยฃ1.68 | 6.62% |
2011 | ยฃ1.57 | 626.78% |
2010 | ยฃ0.22 | -95.05% |
2009 | ยฃ4.38 | 56.36% |
2008 | ยฃ2.80 | -449.04% |
2007 | -ยฃ0.80 | -150.98% |
2006 | ยฃ1.57 | -3.32% |
2005 | ยฃ1.63 | -20.08% |
2004 | ยฃ2.04 | -10.81% |
2003 | ยฃ2.28 | -6.92% |
2002 | ยฃ2.45 | 0% |
2001 | ยฃ2.45 | 7.43% |
2000 | ยฃ2.28 | 17.93% |
1999 | ยฃ1.94 | 13.06% |
1998 | ยฃ1.71 | 15.63% |
1997 | ยฃ1.48 | 20% |
1996 | ยฃ1.23 |